Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.83T
| $12.5B | 6.79% |
29,606,276
-499,410
| -2% | -$202M |
|
2
NVIDIA
NVDA
$5.06T
| $8.63B | 4.71% |
95,570,020
-2,387,560
| -2% | -$173M |
|
|
3
Amazon
AMZN
$2.51T
| $5.53B | 3.02% |
30,670,771
+1,687,922
| +6% | +$282M |
|
4
Meta Platforms (Facebook)
META
$1.54T
| $5.31B | 2.89% |
10,928,772
-32,885
| -0.3% | -$14.7M |
|
|
5
Apple
AAPL
$4.72T
| $5.02B | 2.74% |
29,260,964
-2,407,515
| -8% | -$438M |
|
6
Alphabet (Google) Class C
GOOG
$3.88T
| $4.1B | 2.24% |
26,929,445
-2,087,808
| -7% | -$301M |
|
7
Mastercard
MA
$469B
| $3.66B | 2% |
7,602,104
-127,540
| -2% | -$58.3M |
|
8
Eli Lilly
LLY
$1.06T
| $2.78B | 1.52% |
3,575,684
+243,729
| +7% | +$173M |
|
9
UnitedHealth
UNH
$385B
| $2.63B | 1.43% |
5,316,669
-321,279
| -6% | -$163M |
|
10
AbbVie
ABBV
$454B
| $1.98B | 1.08% |
10,898,246
+1,240,434
| +13% | +$214M |
|
11
Lam Research
LRCX
$400B
| $1.89B | 1.03% |
19,493,190
-2,836,420
| -13% | -$250M |
|
12
Booking.com
BKNG
$134B
| $1.87B | 1.02% |
12,858,400
+549,225
| +4% | +$78.3M |
|
13
Progressive
PGR
$120B
| $1.81B | 0.99% |
8,752,566
-196,664
| -2% | -$36.5M |
|
|
14
Oracle
ORCL
$346B
| $1.62B | 0.88% |
12,872,300
+7,699,141
| +149% | +$881M |
|
15
Deere & Co
DE
$165B
| $1.59B | 0.86% |
3,859,021
+19,200
| +0.5% | +$7.36M |
|
16
JPMorgan Chase
JPM
$930B
| $1.41B | 0.77% |
7,026,491
-836,538
| -11% | -$151M |
|
17
Merck
MRK
$322B
| $1.38B | 0.75% |
10,461,164
-1,595,753
| -13% | -$197M |
|
18
KLA
KLAC
$286B
| $1.36B | 0.74% |
19,405,620
-1,688,070
| -8% | -$108M |
|
19
TJX Companies
TJX
$170B
| $1.34B | 0.73% |
13,226,465
+346,938
| +3% | +$33.6M |
|
20
Boston Scientific
BSX
$64.8B
| $1.27B | 0.7% |
18,612,204
-838,413
| -4% | -$53.9M |
|
21
Advanced Micro Devices
AMD
$880B
| $1.26B | 0.69% |
6,981,790
-1,083,606
| -13% | -$189M |
|
22
Texas Instruments
TXN
$259B
| $1.25B | 0.68% |
7,157,312
-101,629
| -1% | -$16.9M |
|
23
Teleflex
TFX
$5.81B
| $1.22B | 0.67% |
5,409,317
+581,312
| +12% | +$138M |
|
|
24
Workday
WDAY
$31.6B
| $1.21B | 0.66% |
4,450,001
-2,038,334
| -31% | -$580M |
|
25
Adobe
ADBE
$84.3B
| $1.21B | 0.66% |
2,398,106
-388,577
| -14% | -$223M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.